Pulmonx (LUNG) Shares Outstanding (Weighted Average) (2019 - 2025)

Pulmonx (LUNG) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $41.7 million in Q4 2025.

• Quarterly Shares Outstanding (Weighted Average) rose 6.55% year-over-year to $41.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $41.7 million (up 6.55% YoY) and the FY2025 annual result came in at $41.7 million, up 6.55% from the prior year.
• Shares Outstanding (Weighted Average) advanced to $41.7 million in Q4 2025 per LUNG's latest filing, from $40.4 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $41.7 million in Q4 2025 and bottomed at $35.7 million in Q1 2021.
• The 5-year median for Shares Outstanding (Weighted Average) is $37.8 million (2023), against an average of $38.1 million.
• The widest annual swing landed in 2021, when Shares Outstanding (Weighted Average) jumped 1776.17%; it then grew 1.87% in 2023.
• Tracing LUNG's Shares Outstanding (Weighted Average) over 5 years: stood at $36.1 million in 2021, then increased by 2.68% to $37.1 million in 2022, then grew by 2.37% to $38.0 million in 2023, then increased by 2.99% to $39.1 million in 2024, then climbed by 6.55% to $41.7 million in 2025.
• Per Business Quant, the three latest LUNG Shares Outstanding (Weighted Average) figures stand at $41.7 million (Q4 2025), $40.4 million (Q3 2025), and $40.2 million (Q2 2025).

Peer Comparison